This entry has been replaced by an amended communication:
376237-624324
|
Registrant name:
|
William Shelling
|
|
Client:
|
Emergent BioSolutions Canada Inc.
|
|
Associated registration:
|
952671-376237-5
|
|
Communication date:
|
2024-10-09
|
|
Posted date:
|
2024-11-15
|
|
Designated Public Office Holders who participated in the communication:
|
Matthew Trnkus,
Policy advisor
Global Affairs Canada (GAC)
|
| |
List of Details
|
Subject matter
|
Detail
|
|
Aboriginal Affairs,
Consumer Issues,
Defence,
Government Procurement,
Health,
Justice and Law Enforcement,
Research and Development
|
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
|
|
| |
|
Communication report replaced on:
|
2024-12-03
amended entry:
376237-624324
|
| |
